Research Assistant Professor, Department of Epidemiology & Population Health
I am interested in disparities in HIV treatment and care outcomes, cardiovascular disease in HIV infection, use of public health surveillance data, and geographic analysis of health data.
Hanna DB, Post WS, Deal JA, Hodis HN, Jacobson LP, Mack WJ, Anastos K, Gange SJ, Landay AL, Lazar JM, Palella FJ, Tien PC, Witt MD, Xue X, Young MA, Kaplan RC, Kingsley LA (2015). HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin Infect Dis, ePub 22 Apr 2015.
Gingo MR, Zhang Y, Ghebrehawariat KB, Jeong J-H, Chu Y, Yang Q, Lucht L, Hanna DB, Lazar JM, Gladwin MT, Morris A (2015). Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort. PLOS ONE 10: e0123389.
Wiewel EW, Torian LV, Hanna DB, Bocour A, Shepard CW (2015). Foreign-born persons diagnosed with HIV: Where are they from and where were they infected? AIDS Behav, ePub 19 Dec 2014.
Kuniholm MH, Hanna DB, Landay AL, Kaplan RC, Ley K (2014). sCD163 is associated with non-invasive measures of liver fibrosis in HCV- and HCV/HIV-infected women. Hepatology 61: 734-735.
Kaplan RC, Avilés-Santa ML, Parrinello CM, Hanna DB, Jung M, Castañeda SF, Hankinson AL, Isasi CR, Birnbaum-Weitzman, O, Kim RS, Daviglus ML, Talavera GA, Schneiderman N, Cai J (2014). Body mass index, sex, and cardiovascular disease risk factors among Hispanic/Latino adults: Hispanic Community Health Study/Study of Latinos. J Am Heart Assoc 3: e000923.
Shaked I*, Hanna DB*, Gleißner C, Marsh B, Plants J, Tracy D, Anastos K, Cohen M, Golub ET, Karim R, Lazar J, Prasad V, Tien PC, Young MA, Landay AL, Kaplan RC, Ley K (2014). Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with HIV or HCV infection. Arterioscler Thromb Vasc Biol 34: 1085-1092. *Co-first author.
Hanna DB, Hessol NA, Golub ET, Cocohoba JM, Cohen MH, Levine AM, Wilson TE, Young M, Anastos K, Kaplan RC (2014). Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr 65: 587-596.
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ for the NA-ACCORD (2013). Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLOS ONE 8: e78952.
Alonso CD, Dufresne SF, Hanna DB, Labbé A-C, Treadway SB, Neofytos D, Bélanger S, Huff CA, Laverdière M, Marr KA (2013). Clostridium difficile infection after adult autologous stem cell transplantation: A multicenter study of epidemiology and risk factors. Biol Blood Marrow Transplant 19: 1502-1508.
Wiewel EW, Torian LV, Nasrallah HN, Hanna DB, Shepard CW (2013). HIV diagnosis and utilisation of HIV-related medical care among foreign-born persons in New York City, 2001-2009. Sex Transm Inf 89: 380-382.
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ for the NA-ACCORD (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis 56: 1174-1182.
Stuart EA, Hanna DB (2013). Commentary: Should epidemiologists be more sensitive to design sensitivity? Epidemiology 24: 88-89.
Althoff KN, Buchacz K, Hall IH, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne JE, Crane HM, Mugavero MJ, Napravnik S, Kirk GD, Jacobson LP, Brooks JT for the NA-ACCORD (2012). U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med 157: 325-335.
Alonso CD, Treadway SB, Hanna DB, Huff CA, Neofytos D, Carroll KC, Marr KA (2012). Epidemiology and outcomes of Clostridium difficile infections in hematopoietic cell transplant recipients. Clin Infect Dis 54: 1053-1063.
Hanna DB, Selik RM, Tang T, Gange SJ (2012). Disparities among U.S. states in HIV-related mortality in persons with HIV infection, 2001-2007. AIDS 26: 95-103.
Hanna DB, Pfeiffer MR, Sackoff JE, Selik RM, Begier EM, Torian LV (2009). Comparing the National Death Index and the Social Security Administration’s Death Master File to ascertain death in HIV surveillance. Public Health Rep 124: 850-860.
Hanna DB, Tsoi BW, Begier EM (2009). Most positive HIV-1 western blots do not diagnose new cases in New York City: Implications for HIV testing programs. J Acquir Immune Defic Syndr 51: 609-614.
Hanna DB, Pfeiffer MR, Torian LV, Sackoff JE (2008). Concurrent HIV/AIDS diagnosis increases the risk of short-term HIV-related death among persons newly diagnosed with AIDS. AIDS Patient Care STDs 22: 17-28.
Hanna DB, Gupta LS, Jones LE, Thompson DM, Kellerman SE, Sackoff JE (2007). AIDS-defining opportunistic illnesses in the HAART era in New York City. AIDS Care 19: 264-272.
Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV (2006). Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 145: 397-406.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Belfer Building, Room 1306C
Bronx, NY 10461